Lactulose
Who holds supplier records for Lactulose? 8 organisations hold a current record for Lactulose: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: France (1), China (1), Denmark (1), Austria (1) and 4 other countries (4).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Lactulose: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/lactulose
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Lactulose. Country is the organisation's recorded country, not necessarily the manufacturing site.
- API PHARMA TECH LLCFranceActive DMF 42605 · latest filing Oct 2025
- SYNGARS TECHNOLOGY CO LTDChinaActive DMF 38252 · latest filing Mar 2023
- Danipharm A/SDenmarkCEP
- AustriaCEP Company GMP cert on record
- IndiaCEP
- MaltaCEP
- ABBOTT LABORATORIES CO. VictoriavilleCanadaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- ABBOTT HEALTHCARE PRODUCTS B.V.NetherlandsCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (6)
Certificates of Suitability on the EDQM register for Lactulose, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| LACTOSE (INDIA) LIMITED Mumbai | IN | CEP 2025-451 - Rev 00 Lactulose, liquid, 620 g/l | Apr 2026 | — |
| Fresenius Kabi Austria GmbH Linz | AT | CEP 2019-138 - Rev 01 Lactulose, liquid, 667 g/L | Aug 2024 | Inspected May 2025 Austria |
| ABBOTT LABORATORIES CO. Victoriaville | CA | R1-CEP 2005-102 - Rev 05 Lactulose, liquid, 634 g/l to 700 g/l | Feb 2020 | — |
| RELAX LIMITED Luqa | MT | R1-CEP 1999-168 - Rev 03 Lactulose, liquid, 660 g/l, 700 g/l | Aug 2014 | — |
| Danipharm A/S Kastrup | DK | R1-CEP 2002-162 - Rev 02 Lactulose, liquid, 620 g/l to 700 g/l | Nov 2013 | — |
| ABBOTT HEALTHCARE PRODUCTS B.V. Weesp | NL | R1-CEP 1997-060 - Rev 04 Lactulose, liquid, 667g/l | Jun 2010 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Lactulose are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- SOLVAY DUPHAR BVInactive DMF 12699 · filed Oct 1997
- Italy · Inactive DMF 7833 · filed Dec 1988
Overview
Lactulose is a non-digestible synthetic disaccharide used as a laxative to treat constipation and hepatic encephalopathy. It works by increasing the number of bowel movements per day and the number of days of bowel movements.
Chemical identity
- IUPAC name
- (3S,4R,5R)-1,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-one
- Canonical SMILES
- C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H](C(=O)CO)O)O)O)O)O
- InChIKey
- PFCRQPBOOFTZGQ-VZXVHDRGSA-N
- Synonyms
- Enulose API, 4-galactosyl fructose, acilac, cephulac, cholac, chronulac, constilac, constulose, duphalac, enulose, evalose, generlac
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Osmotic Laxative
- Mechanism of action
- Acidifying Activity; Osmotic Activity
- Physiologic effect
- Stimulation Large Intestine Fluid/Electrolyte Secretion
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Lactulose?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Lactulose: API PHARMA TECH LLC (France), SYNGARS TECHNOLOGY CO LTD (China), Danipharm A/S (Denmark), FRESENIUS KABI AUSTRIA GMBH (Austria), LACTOSE (INDIA) LTD (India), RELAX LTD (Malta), ABBOTT LABORATORIES CO. Victoriaville (Canada) and ABBOTT HEALTHCARE PRODUCTS B.V. (Netherlands). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Lactulose Drug Master Files are active?
API PHARMA TECH LLC (DMF 42605) and SYNGARS TECHNOLOGY CO LTD (DMF 38252). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Lactulose records mean?
2 organisations have only inactive Type II DMFs for Lactulose. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Lactulose have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Lactulose on the EDQM register, including LACTOSE (INDIA) LIMITED Mumbai (IN), Fresenius Kabi Austria GmbH Linz (AT), ABBOTT LABORATORIES CO. Victoriaville (CA), RELAX LIMITED Luqa (MT), Danipharm A/S Kastrup (DK) and ABBOTT HEALTHCARE PRODUCTS B.V. Weesp (NL). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Lactulose supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Lactulose?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.